Frederick, MD, United States of America

Kirk P Manfredi


Average Co-Inventor Count = 8.6

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Cedar Falls, IA (US) (1995)
  • Frederick, MD (US) (1995 - 1997)

Company Filing History:


Years Active: 1995-1997

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kirk P Manfredi: Innovator in Antiviral Compounds

Introduction

Kirk P Manfredi is a notable inventor based in Frederick, MD (US). He has made significant contributions to the field of antiviral compounds, holding a total of 3 patents. His work focuses on the development of new antiviral agents that have the potential to treat viral infections effectively.

Latest Patents

Manfredi's latest patents include innovative processes for preparing michellamine compounds. These inventions provide new antiviral compounds, specifically michellamines and their derivatives, along with pharmacologically acceptable salts. The methods outlined in his patents detail how to isolate these antiviral compounds from a plant species of the genus Ancistrocladus. Furthermore, the antiviral compositions developed by Manfredi are designed to inhibit the reproduction and cytopathicity of human acquired immunodeficiency viruses.

Career Highlights

Throughout his career, Kirk P Manfredi has worked with various esteemed organizations. Notably, he has been associated with the United States of America as represented by the Secretary of Health and the Department of Health. His work has contributed to advancements in antiviral research and treatment methodologies.

Collaborations

Some of his notable coworkers include Michael R Boyd and Gerhard Bringmann. Their collaborative efforts have furthered the research and development of antiviral compounds.

Conclusion

Kirk P Manfredi's innovative work in the field of antiviral compounds showcases his dedication to improving treatment options for viral infections. His patents reflect a significant advancement in medical research, highlighting the importance of continued innovation in this critical area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…